Association of interleukin-4 receptor gene polymorphisms with rheumatoid arthritis in Egyptian female patients

Joint Bone Spine

Volumn 79, Issue 1, 2012, Pages 38-42

  Hussein, Yousri ^a   El Tarhouny, Shereen ^a   Mohamed, Randa ^a   Pasha, Heba ^a   Abul Saoud, Amany ^a  

^a ZAGAZIG UNIVERSITY   (Egypt)

Author keywords

IL 4R ; Polymorphisms; Rheumatoid arthritis

Indexed keywords

INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR; INTERLEUKIN 4 RECEPTOR ALPHA;

ADULT; AGED; ARTHROPATHY; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; EGYPT; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; PATHOGENESIS; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RHEUMATOID ARTHRITIS;

ADULT; AGED; ARTHRITIS, RHEUMATOID; DNA; EGYPT; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HEALTH STATUS; HUMANS; INTERLEUKIN-4 RECEPTOR ALPHA SUBUNIT; MIDDLE AGED; POLYMORPHISM, GENETIC; SEVERITY OF ILLNESS INDEX;

EID: 84855706833     PISSN: 1297319X     EISSN: 17787254     Source Type: Journal    
DOI: 10.1016/j.jbspin.2011.02.017     Document Type: Article

References (38)

1. Firestein G.S. Evolving concepts of rheumatoid arthritis. Nature 2003, 423:356-361.
2. Deighton C.M., Walker D.J. The familial nature of rheumatoid arthritis. Ann Rheum Dis 1991, 50:62-65.
3. MacGregor A.J., Snieder H., Rigby A.S., et al. Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins. Arthritis Rheum 2000, 43:30-37.
4. John S., Myerscough A., Marlow A., et al. Linkage of cytokine genes to rheumatoid arthritis. Evidence of genetic heterogeneity. Ann Rheum Dis 1998, 57:361-365.
5. Williams R.O., Feldmann M., Maini R.N. Cartilage destruction and bone erosion in arthritis: the role of tumour necrosis factor alpha. Ann Rheum Dis 2000, 59:i75-i80.
6. Lee D.M., Weinblatt M.E. Rheumatoid arthritis. Lancet 2001, 358:903-911.
7. O'Dell J.R. Treating rheumatoid arthritis early: a window of opportunity?. Arthritis Rheum 2002, 46:283-285.
8. Prots I., Skapenko A., Wendler J., et al. Association of the IL4R single-nucleotide polymorphism I50V with rapidly erosive rheumatoid arthritis. Arthritis Rheum 2006, 54:1491-1500.
9. Skapenko A., Niedobitek G.U., Kalden J.R., et al. The Th2 cytokines IL-4 and IL-10 are internal controllers of human Th1-biased immunity in vivo. Arthritis Res Ther 2003, 5(Suppl. 3):88.
10. Aggarwal S., Ghilardi N., Xie M.H., et al. Interleukin-23 promotes a distinct CD4T cell activation state characterized by the production of interleukin-17. J Biol Chem 2003, 278:1910-1914.
11. Lubberts E. IL-17/Th17 targeting: on the road to prevent chronic destructive arthritis?. Cytokine 2008, 41:84-91.
12. Boyle D.L., Nguyen K.H.Y., Zhuang S., et al. Intra-articular IL-4 gene therapy in arthritis: anti-inflammatory effect and enhanced th2 activity. Gene Ther 1999, 6:1911-1918.
13. Yoshino S. Effects of a monoclonal antibody against interleukin-4 on collagen-induced arthritis in mice. Br J Pharmacol 1988, 123:237-242.
14. Raza K., Falciani F., Curnow S.J., et al. Early rheumatoid arthritis is characterized by a distinct and transient synovial fluid cytokine profile of T cell and stromal cell origin. Arthritis Res Ther 2005, 7:R784-R795.
15. Nelms K., Keegan A., Zamorano J., et al. The IL-4-receptor: signaling mechanisms and biologic functions. Annu Rev Immunol 1999, 17:701-738.
16. Deichmann K., Bardutsky J., Forster J., et al. Common polymorphisms in the coding part of the IL-4 receptor gene. Biochem Biophys Res Commun 1997, 231:696-697.
17. Mitsuyasu H., Izuhara K., Mao X.Q., et al. Ile50Val variant of IL-4R upregulates IfE synthesis and associates with atopic asthma. Nat Genet 1998, 19:119-120.
18. Arnett F.C., Edworthy S.M., Bloch D.A., et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988, 31:315-324.
19. Sharp J.T. An overview of radiographic analysis of joint damage in rheumatoid arthritis and its use in metaanalysis. J Rheumatol 2000, 27:254-260.
20. Eda S., Kaufmann J., Roos W., et al. Development of a new microparticle-enhanced turbidimetric assay for C-reactive protein with superior features in analytical sensitivity and dynamic range. J Clin Lab Anal 1998, 12:137-144.
21. Noguchi E., Shibasaki M., Arinami T., et al. No association between atopy/asthma and the ILe50Val polymorphism of IL-4 receptor. Am J Respir Crit Care Med 1999, 160:342-345.
22. Sandford A.J., Chagani T., Zhu S., et al. Polymorphisms in the IL4, IL4RA, and FCERIB genes and asthma severity. J Allergy Clin Immunol 2000, 106:135-140.
23. Sokka T., Pincus T. Markers for work disability in rheumatoid arthritis. J Rheumatol 2001, 28:1718-1722.
24. Kirwan J.R. Links between radiological change, disability, and pathology in rheumatoid arthritis. J Rheumatol 2001, 28:881-886.
25. Whitacre C.C., Reingold S.C., O'Looney P.A., et al. A gender gap in autoimmunity. Science 1999, 283:1277-1278.
26. Al-Shamri S., Rawoot P., Azizieh F., et al. Th1/Th2 cytokine patterns and clinical profiles during and after pregnancy in women with multiple sclerosis. J Neurol Sci 2004, 222:21-27.
27. Elenkov I.J., Hoffman J., Wilder R.L. Does differential neuroendocrine control of cytokine production control the expression of autoimmune diseases in pregnancy and the postpartum period?. Mol Med Today 1997, 9:379-383.
28. Pawlik A., Wrzesniewska J., Florczak M., et al. The -590 IL-4 promoter polymorphism in patients with rheumatoid arthritis. Rheumatol Int 2005, 26:48-51.
29. Marinou I., Till S.H., Moore D.J., et al. Lack of association or interactions between the IL-4, IL-4Rα and IL-13 genes, and rheumatoid arthritis. Arthritis Res Ther 2008, 10:R80.
30. Burgos P.I., Causey Z.L., Tamhane A., et al. Association of IL4R single nucleotide polymorphisms with rheumatoid nodules in African Americans with rheumatoid arthritis. Arthritis Res Ther 2010, 12:R75.
31. Ford A.Q., Heller N.M., Stephenson L., et al. An atopy-associated polymorphism in the ectodomain of the IL-4Rα chain (V50) regulates the persistence of STAT6 phosphorylation1. J Immunol 2009, 183(3):1607-1616.
32. Hanson E.M., Dickensheets H., Qu C.K., et al. Regulation of the dephosphorylation of Stat6. Participation of Tyr-713 in the interleukin-4 receptor alpha, the tyrosine phosphatase SHP-1, and the proteasome. J Biol Chem 2003, 278(6):3903-3911.
33. Saaibi D.L. Factor reumatoideo y otros auotanticuerpos en artritis reumatoide. Artritis reumatoide 2004, 117-125. Editorial Edimeco SA, Bogotá 2nd ed. L.A. Ramírez, J.-M. Anaya (Eds.).
34. Bukhari M., Lunt M., Harrison B.J., et al. Rheumatoid factor is the major predictor of increasing severity of radiographic erosions in rheumatoid arthritis. Arthritis Rheum 2002, 46:906-912.
35. Nielen M.M., van Schaardenburg D., Reesink H.W., et al. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum 2004, 50:380-386.
36. Moreno O., Gonzalez C.I., Saaibi D.L., et al. Polymorphisms in the IL4 and IL4RA genes in Colombian patients with rheumatoid arthritis. J Rheumatol 2007, 34:36-42.
37. Stephenson L., Johns M.H., Woodward E., et al. An IL-4Ra allelic variant, I50, acts as a gain-of-function variant relative to V50 for STAT6, but not Th2 differentiation. J Immunol 2004, 173:4523-4528.
38. Shirakawa T., Deichmann K.A., Izuhara K., et al. Atopy and asthma: genetic variants of IL-4 and IL-13 signalling. Immunol Today 2000, 21:60-64.